RDY Other Current Liab from 2010 to 2025

RDY Stock  USD 13.60  0.39  2.79%   
Dr Reddys Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities is likely to outpace its year average in 2025. During the period from 2010 to 2025, Dr Reddys Other Current Liabilities regression line of annual values had r-squared of  0.03 and arithmetic mean of  45,519,949,125. View All Fundamentals
 
Other Current Liabilities  
First Reported
2000-03-31
Previous Quarter
45.7 B
Current Value
47.4 B
Quarterly Volatility
38.1 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Pretty Stable
   Other Current Liab   
       Timeline  

RDY Other Current Liab Regression Statistics

Arithmetic Mean45,519,949,125
Geometric Mean22,818,530,097
Coefficient Of Variation87.24
Mean Deviation24,977,275,656
Median39,361,000,000
Standard Deviation39,710,190,949
Sample Variance1576899265.2T
Range175.9B
R-Value0.18
Mean Square Error1637392937.2T
R-Squared0.03
Significance0.52
Slope1,465,272,368
Total Sum of Squares23653488978.5T

RDY Other Current Liab History

202570.2 B
202466.8 B
202358.1 B
202253.5 B
202148.3 B
202045.3 B
201939.4 B

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities66.8 B70.2 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.